Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 28/03/2025 | Baxter Healthcare Corporation |
U.S.A |
Baxter Oncology GmbH | 69443-406 | trastuzumab deruxtecan | 2019-05-22 | 2025-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/5mL) |
| 28/03/2025 | Bamboo US Bidco LCC | 83703-580 | trastuzumab deruxtecan | 2019-05-22 | 2025-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/5mL) |
